Our comprehensive service offering includes early stage formulation and analytical development for both highly potent and non-potent drug products.
We are able to offer API directly into capsules and vials using microdosing technology as well as the more traditional development pathways. The use of microdosing Drug in Capsule (DiC) and Drug in Vial (DiV) approach offers both time and cost efficiencies as well as the potential to reduce wastage of often expensive APIs.
Following early stage development, we continue with further development, scale-up, and process validation ahead of commercial launch for a variety of dosage forms, all supported by full in-house analytical development and release laboratory.
We have the capability to deliver at any stage of your sterile fill-finish project with expertise and to tight timelines, managing solubility and stability challenges as well as assisting with challenging formulation processes.
Our global manufacturing capabilities in complex formulations, high potency, and lyophilization covers a broad range of injectables including nanoparticles, mRNA, MABs, proteins, oligonucleotides, and other biologics across multiple delivery formats from vials and bottles to prefilled syringes and autoinjectors.
We provide integrated large and small molecule solutions for clinical and commercial projects, and with over 20 years in the sterile fill-finish and lyophilization manufacturing space, we are dedicated to your success in life changing therapies.
Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation, and analytical development for both highly potent and non-potent drug products.
At PCI, we provide full drug development and manufacturing services for both investigational and commercial products including highly potent molecules requiring specialist handling. With over 35 years of experience of processing potent and non-potent drug products, PCI provides a partnership and consultative approach from pre-clinical formulation development and API characterization through to full commercial launch.
